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ABSTRACT  Mouse  lymphoma  cells  ($49) that grow in  suspension  culture  were selected  for 
increased  tumorigenicity through continuous passages in syngeneic BALB/c  mice. Developing 
tumors were classified  as  high grade  malignant  lymphoma,  small  noncleaved  type. Variants 
were selected  from these tumorigenic  cells that were able to grow as a monolayer attached 
to their  substrate,  resembling,  in  this  respect,  fibroblastoid  cells.  Whereas  the  tumorigenic 
suspension-growing parental cells were able to induce progressive  tumors with an inoculum 
as low as 100 cells  per mouse, the adherent cells were unable to develop as tumors even at 
an inoculum of 1 x  108 cells per mouse. In addition, mice inoculated once with live adherent 
cells  were immunized  against  1 x  107 suspension-growing cells.  Involvement  of an immune 
response  in  the  rejection  of tumorigenic  $49  cells  was  suggested  by  (a)  adoptive  transfer 
experiments  in which  spleen  cells  from  immunized  mice  protected  naive  mice and  (b) the 
appearance of antibodies in the sera of immunized syngeneic mice that specifically recognized 
both adherent and suspension-growing $49 cells and detected differences in [35S]methionine- 
labeled antigens from these cells. Antibodies raised in rabbits against adherent cells recognized 
three  proteins  of  34,000,  61,000,  and  72,000  apparent  molecular  weight  in  radiolabeled 
adherent  cell  extracts  that  are  either  absent  or  present  in  small  amounts  in  extracts  of 
suspension-growing tumorigenic  $49 cells.  These findings,  taken together with our previous 
report (Hochman, J., A. Katz, E. Levy, and S. Eshel, 1981, Nature (Lond.), 290:248-249), suggest 
the $49 system as a novel system for studying growth control in malignant lymphoid cells. 
The relationship among cell  adhesiveness (the ability to ad- 
here to other cells and to extracellular substrata), transfor- 
mation, tumor development, and the metastatic behavior of 
malignant cells is a  well-known but complex phenomenon 
that has been studied extensively (l, 3, 5, 9,  18, 20, 24) since 
Ludford (17) and Cowdry (6) first suggested that membranes 
of tumor cells had lower general adhesive properties than the 
normal cells  from which they were derived. These previous 
studies have all been carried out on cells grown as monolayers 
(i.e.,  fibroblastoid) attached to their substratum and to each 
other. 
We have undertaken to study this relationship in malignant 
lymphoid cells that grow attached neither to each other nor 
to  their  substratum.  Our  working  hypothesis  is  that  if in 
fibroblasts  decreased  cell  adhesiveness  correlates  with  in- 
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creased tumorigenicity (3,  18) and vice versa, then isolation 
of adherent  variants  from  malignant  lymphoid  cells  may 
result in decreased tumorigenicity. Such a model would be of 
potential significance in the study of in vitro growth regulation 
of malignant lymphoid cells. 
To test this approach, we have used $49  cells--a mouse 
lymphoma cell line  of BALB/c  origin  (13).  We  have first 
demonstrated that stable variants can be isolated, character- 
ized by their ability to adhere to their substratum (bottom of 
culture flask) and divide while attached to it (11).  Using the 
same approach, we have subsequently isolated substrate-ad- 
hering variants from tumorigenic $49 cells, previously selected 
through continuous in vivo passages in BALB/c mice (12). 
We have also found that the adherent $49  variants demon- 
strated impaired tumorigenicity, while concomitantly being 
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with tumorigenic suspension-growing $49 cells. 
In the present report, we extend our previous findings by 
characterizing the parental  $49  tumors and demonstrating 
that the adherent cells are directly derived from suspension- 
growing $49 cells. We also show that selection for adherent 
variants decreases their tumorigenicity by several orders of 
magnitude. This decreased tumorigenicity appears to be based 
on  an  immune  response in  the  host:  immune  protection 
following a single inoculation of viable adherent cells is effec- 
tive for a long period of time, the serum of the immunized 
mice  contains  antibodies  that  recognize both  suspension- 
growing and adherent $49 cells, and there are antigenic dif- 
ferences between adherent and suspension-growing cells based 
on immunoprecipitation of [3SS]methionine-labeled  cell ex- 
tracts  with  syngeneic mouse  antisera  and  with  antibodies 
raised in rabbits. Taken together, these findings suggest that 
$49 cells and their adherent variants are a  valuable model 
system to probe the molecular mechanism(s) involved in the 
relationship between cell adhesiveness and growth regulation 
in malignant lymphoid cells. 
MATERIALS  AND  METHODS 
Cells:  Parental  $49 cells (maintained  in stationary  suspension culture) 
and the substrate-adhering  variants derived from them were grown in Dulbec- 
co's modified  Eagle medium supplemented  with  10%  heat-inactivated  horse 
serum, penicillin (50 U/ml), and streptomycin  (50 t,g/ml).  Cells were main- 
tained  at 37"C in a humidified  atmosphere  containing  5% CO2. Viability was 
measured using trypan blue exclusion. 
Tumors:  Unless  otherwise  specified,  1-2  x  107  cells were inoculated 
intraperitoneally  into 8-10-wk-old  male BALB/c  mice from which  the $49 
cells were originally derived (13). Mice were checked daily. The first day that 
tumors could  be  recognized  was recorded.  Mice  were  obtained  from  the 
breeding colony of the Hebrew University. They were kept in groups of six to 
ten per cage and fed Purina Chow and water ad lib. 
Adherent Cells:  Selection of substrate-adbering variants from suspen- 
sion-growing tumorigenic parental cells was carried out as previously described 
(11) through continuous selection and enrichment of spontaneously appearing 
adherent cells. 
Adoptive Transfer:  Spleen cells from BALB/c mice that were previ- 
ously  (60-90  d)  inoculated  with  a  single dose  of adherent  $49  cells were 
inoculated  intraperitoneally  (~108 cells) into BALB/c mice 30 rain before an 
intraperitoneal  inoculation  of 1 x  107 suspension-growing  tumorigenic  $49 
cells. Spleen cells from naive mice were used as controls. Mice were checked as 
described above. 
Fluorescence-activated Cell Sorter Analysis:  Cell-sorter  anal- 
ysis was carded out on sera derived from BALB/c mice immunized with  1 x 
107 live adherent  $49 cells as described in the legend to Table I and unimmu- 
nized BALB/c controls.  All sera were incubated  with suspension-growing as 
well as adherent  cell populations  (45  rain at 4"C) extensively washed  with 
Hank's solution  (without  phenol  red) and incubated  with fluorescein--conju- 
gated goat anti-mouse lgG (Cappel Laboratories,  Inc., Conchranville,  PA) for 
45  min at 4"C. Samples were analyzed  with the FACS-II cell sorter (Becton 
Dickinson Immunocytometry  Systems, Oxnard, CA). Fluorescence units (F.U.) 
represent the median (corrected for a gain of 16) of the curve generated when 
cell numbers are plotted versus fluorescence intensity. 
Immunoprecipitations:  [~SS]methionine-labeled $49  parental  and 
adherent  cells  were  prepared  as described  by  Steinberg  and  Cofllno  (23). 
Detergent-soluble extracts for immunoprecipitation  were prepared in buffer A 
(0.154 M NaCI, 0.5 M Tris-HCI, pH 7.4, 0.5% Nonidet  P-40, 0.05% SDS, 2 
mM EDTA, and 1% aprotinin [Sigma Chemical Co., St. Louis, MO]) and had 
a specific activity of 4.2 x  l0  T  trichloroacetic acid-precipitable  cpm/ml for $49 
parental cells and 1.3 x  107 cpm/ml for adherent cells. Antisera to $49 parental 
cells and adherent cells were prepared by repeated subcutaneous inoculation  of 
formalin-fixed cells in Freund's incomplete adjuvant into rabbits, lmmunopre- 
cipitations were as described by Gottesman and Cabral (8) using the Staphylo- 
coccus aureus method of Kessler (14). Aliquots of each extract containing  5 x 
l0  s cpm were immunoprecipitated  for the immunoprecipitations  with rabbit 
antisera.  For the immunoprecipitations  with antiserum from syngeneic mice 
which had been inoculated with 2 x  107 live adherent  $49 ceils, 1 x  l0  T  cpm 
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were used. Goat anti-murine leukemia virus was from the Bureau of Biologics. 
Immunoprecipitated  extracts  were exposed  to SDS PAGE  according  to the 
method of Laemmli  (16) with a  5%  stacking gel and a  10%  separating gel. 
Fluorography  of the radiolabeled samples was done according to Bonner and 
Laskey (2). A series of 14C-labeled protein standards (Amersham Corp., Arling- 
ton Heights, IL) provided molecular weight markers. 
RESULTS 
Derivation of Tumorigenic 549 Cell Lines 
In our study, $49  cells propagated in suspension culture 
were readapted to grow as transplantable tumors in BALB/c 
mice, from which they were originally derived. Selection for 
cells with increased tumorigenicity was carded out through 
serial passages  in BALB/c males (Fig.  1). Thus, at the first 
passage only one mouse out of five developed a tumor within 
32 d  postinoculation, whereas at the 25th passage,  tumors 
appeared within 7-10 d  and all mice died within  13-15 d 
postinoculation. For further experimentation, we have used 
sublines derived from tumors of the  25th and  subsequent 
passages,  respectively. Whereas the above-mentioned inocu- 
lations were performed intraperitoneally, we have found that 
both intravenous and subcutaneous inoculation resulted in 
tumor development as well (data not shown). 
Tumor Histopathology 
Extensive involvement by  grayish  tumorous  tissue  was 
found in many organs of  the dead mice. The tumorous masses 
infiltrated the mesentery, the retroperitoneum, and the peri- 
toneal cavity causing ascites. The tumor invaded the muscles 
of the extremities and abdomen producing large masses be- 
neath the skin. The most involved organs were the pancreas, 
small and large intestine, epididymis, testes, and thymus. The 
spleen, meninges, and brain were spared. 
The histological picture of the tumor was that of a diffuse 
high grade malignant lymphoma with a  prominent "starry 
sky"  appearance  (Fig.  2).  The  lymphoma  cells  had  little 
cytoplasm with oval nuclei containing a few prominent nu- 
cleoli. Many cells  revealed small cytoplasmic vacuoles that 
stained positively for fat. Many lymph nodes, as well as the 
spleen, were often seen surrounded by the malignant lym- 
phoma but without infdtration into the organs themselves. 
The histological picture according to Rappaport's classifica- 
tion (21) is that of malignant lymphoma, undifferentiated. 
According to the  new formulation (19),  it is a  high grade 
malignant lymphoma, small noncleaved type. 
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FIGURE  1  Time of tumor appearance at various passages in 8ALB/ 
c  mice.  Males  8-10  wk old were inoculated with  2  x  107 cells 
intraperitoneally. Results show the first day at which a tumor could 
be detected: (Q) first, (O) second, (A) third, and (A) 25th passages, 
respectively. 
Cell  Adhesiveness  and Tumorigenicity  in Mouse  Lymphoma  12 83 FIGURE 2  Histological picture of S49 tumor cells. (A) High-grade malignant lymphoma, small noncleaved  type showing prominent 
"starry sky" appearance. (B) Same  tumor mass. The lymphoma cells show little cytoplasm with a few prominent nucleoli. Many 
macrophages show small tingible bodies (arrows). (C) Skin infiltrated by tumor cells showing destruction of the skin adnexa. (D) 
Small intestine infiltrated by masses of tumor cells. (E) Striated muscle extensively infiltrated by the tumor mass. H and E. x  400. 
All except B, hematoxylin and eosin. (A, C, and D) x  105; (B) x  660; (E) x  400. 
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Adhesive Variants 
The suspension-growing subline established from the 25th 
in vitro passage of $49 tumor cells has been designated T-25. 
To study the  role of cell adhesiveness in tumorigenicity of 
lymphoid cells,  we have selected for and isolated a  nonmu- 
tagenized, spontaneous subline (designated T-25-Adh) char- 
acterized by its ability to adhere to the bottom of  tissue culture 
flasks in the presence of serum (12).  Upon adhesion to the 
substrate, these cells continue to divide until a dense mono- 
layer is formed. At this stage daughter cells start to appear 
and proliferate in suspension as single cells or small aggregates 
of a few cells in the medium. When the suspension-growing 
cells derived in this manner are transferred to another culture 
flask, they adhere to the substrate with the same kinetics as 
their parental adherent cells (data not shown). These obser- 
vations suggest that the predominant  interactions  of T-25- 
Adh cells are cell to substrate and not cell to cell. The substrate 
adhesiveness of T-25-Adh cells (and all other adherent sub- 
lines derived so far) is a stable trait insofar as continuous in 
vitro growth for over 18  mo does not affect their substrate 
adhesiveness or their adherent characteristic. It is noteworthy 
that the generation time of T-25-Adh cells  is similar to the 
generation time of T-25 cells (18-20 h). 
To demonstrate that T-25-Adh cells are derived from sus- 
pension-growing $49 cells and are not derived from host cells, 
we took advantage of the fact that $49 cells contain a promi- 
nent  cytoplasmic  marker  system  that  resembles  tubulore- 
ticular structures,  which  can easily be distinguished  at the 
electron microscopic level (10) and is not found in normal 
BALB/c tissues.  These tubular structures are characteristic of 
suspension-growing $49 cells as well as tumors and suspen- 
sion-growing sublines derived from them. We have found by 
electron microscopic analysis that 15/15 clones of $49 adher- 
ent variants demonstrate the same system. 
When  T-25  and  T-25-Adh cells were compared in  their 
ability to develop tumors, a striking difference was found (Fig. 
3).  Whereas in suspension-growing T-25 cells the lowest in- 
oculum that still  gave progressive tumors was  102-103 cells 
per mouse (at that inoculum, tumors developed within 30- 
45 d and mice died within 45-55 d, respectively), with T-25- 
Adh cells, tumors did not develop even at an inoculum of l0  s 
cells per mouse. These mice were followed for up to 270 d 
postinoculation to exclude tumor dormancy. These findings 
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FIGURE  3  Tumorigenicity  of  parental  suspension-growing  T-25 
cells versus the adherent variant T-25-Adh cells selected from them. 
BALB/c  males  were  inoculated  intraperitoneally  with  increasing 
doses of T-25  (0) and T-25-Adh (,) cells.  In group receiving 103- 
106 and 10  a cells, n =  5. In group receiving 102 cells, n = 6. In group 
receiving 10 z cells, n =  16. 
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FIGURE  4  Immunizing potential ability of T-25-Adh cells in synge- 
neic mice.  BALB/c males inoculated intraperitoneally 90 d  earlier 
with  1 x  107 T-25-Adh cells (A)(n =  10) and control BALB]c males 
of  the  same  age  group  (Q)(n  =  4)  were  both  inoculated  with 
tumorigenic T-25 cells (1  x  10 z cells per mouse intraperitoneally). 
Mice were checked daily and the first day at which tumors could 
be recognized was recorded. 
demonstrate that the selection for substrate-adhering $49 cells 
significantly impairs their tumorigenic potential in BALB/c 
mice. 
Immunogenicity of Adherent Cells 
When BALB/c mice that had previously received a single 
injection of 107 T-25-Adh cells were challenged with a highly 
tumorigenic dose (10  7 cells) of T-25 cells, it was found (Fig. 
4) that no tumors developed in these mice for at least 6 mo. 
These findings demonstrate that T-25-Adh cells can confer 
upon a syngeneic host immunity against tumorigenic suspen- 
sion-growing  T-25  cells.  These  experiments were  repeated 
using different, independently selected adherent variants, de- 
rived from clones 24.3.2 and 24.6.1  (4), with the same results. 
In contrast, both T-25 and T-25-Adh cells develop progressive 
tumors in athymic (nu/nu) mice. 
When naive mice (n =  7) were inoculated with the equiva- 
lent of one spleen (~10  s cells) from immunized mice (previ- 
ously  primed  with  T-25-Adh  cells)  and  immediately chal- 
lenged with  107 T-25 cells, five mice were protected (did not 
develop  tumors)  whereas  two  mice  developed  progressive 
tumors. As controls, we used mice (n = 5) that were inoculated 
with the equivalent of one spleen from naive BALB/c mice 
followed by 107 T-25 cells. All mice in that group developed 
progressive tumors. 
The  serum  of immunized  mice  (primed with  T-25-Adh 
cells and challenged with T-25 cells) appears to demonstrate 
antibody activity specific for both T-25-Adh and T-25  cells 
(Table I).  This serum does not react with spleen cells from 
BALB/c or other mice strains. It is noteworthy that greater 
antibody activity is seen on the T-25-Adh cells than on the 
T-25 target cells. 
Quantitative  Differences in Antigens between 
Adherent and Suspension-growing Cells 
To define molecular parameters that might be involved in 
the biological differences between T-25 and T-25-Adh cells, 
we raised antibodies against both formalin-fixed cell types in 
rabbits. [35S]methionine-labeled extracts from both T-25 and 
T-25-Adh cells were subjected to immunoprecipitation with 
the  homologous and  heterologous antisera followed by gel 
electrophoresis and autoradiography (see Materials and Meth- 
ods).  The findings  shown  in  Fig.  5  can  be summarized as 
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nizes three proteins of approximate molecular weight 34,000, 
61,000, and 72,000  (lane  10,  arrows) from T-25-Adh cells. 
This antiserum  does  not  recognize these  proteins in  T-25 
extracts (lane 8) nor does antiserum to T-25 cells recognize 
these proteins in T-25-Adh cells (lane 6). They are not major 
cell proteins (e.g., lanes 1 and 2). These results suggest that 
the T-25-Adh cells have additional antigens not present (or 
present only in small amounts) in the T-25 parental extracts. 
In parallel experiments (data not shown), T-25-Adh extracts 
were  immunoprecipitated with  anti-MuLV  antisera  which 
recognize gpT0 and other antigens in these extracts. In this 
case, the gp70 observed migrated faster on SDS PAGE gels 
than the 72,000-mol-wt antigen detected with our anti-T-25- 
Adh rabbit serum. 
To determine whether T-25 (suspension-growing) cells con- 
tain any antigens that cross-react with the 34,000-,  61,000-, 
and 72,000-mol-wt antigens detected on T-25-Adh cells, we 
had the rabbit antiserum,  which recognizes these antigens, 
adsorbed with an excess of T-25 cells. Fig. 6 shows the results 
TABLE  I 
Cell-sorter Analysis of Interaction between Various Cell Types and 5era of Both Control and Immunized BALB/c Mice 
Immune serum 
Cells  Normal mouse serum  T-25-Adh cells*  T-25-Adh  +  T-25 cells* 
F.U. 
T-25  58+5  (10)  495=[=265(7)  1,042+750  (11) 
T-25-Adh  66 +  29 (9)  1,426 +  510 (7)  2,766 +__ 1,570  (10) 
BALB/c spleen cells  19 +  14 (6)  13 +_ 3  (5)  20 +  13  (7) 
BALB/c fibroblasts  64 (1)  --  64  (1) 
B10, BALB/cH2 din2, B10D2, B10BR  48 (1)  --  48  (1) 
Fluorescence  units (F.U.) are defined in Materials and Methods. The numbers represent the mean +  SD of each set of experiments. The number in parenthesis 
is the number of independent experiments (different mice).  B10, BALB/cH2  dm2, B10D2, and B10BR are spleen cells from various  mouse strains. 
* Mice were immunized with 107 T-25-Adh cells and bled after 3 wk. 
* Immunized mice were primed with 107 T-25-Adh cells, challenged  1 mo later with 107 T-25 cells, and bled after 3 wk. 
FIGURE 5  Immunopre- 
cipitation of three pro- 
teins  specific  to  Adh  + 
cells by rabbit antisera. 
Immunoprecipitations 
were carried out as de- 
scribed under Materials 
and Methods  using an- 
tibodies to $49 parental 
and Adh  + cells  elicited 
in  rabbits.  (lane  1)  1  x 
10  s cpm of $49 parental 
lysate,  no  immunopre- 
cipitation;  (lane 2)  1  x 
10  s cpm of Adh  + lysate, 
no  immunoprecipita- 
tion;  (lane  3)  preim- 
mune  serum  to  S49 
cells (No. 2556), $49 ly- 
sate; (lane 4) antiserum 
to $49 cells (No. 2556), 
$49  lysate;  (lane  5) 
preimmune  serum  to 
$49  cells  (No.  2556), 
Adh  +  lysate;  (lane  6) 
antiserum  to  $49  cells 
(No. 2556), Adh + lysate; 
(lane  7)  preimmune 
serum  to  Adh  +  (No. 
2558),  549 lysate; (lane 
8)  antiserum  to  Adh  + 
cells (No. 2558), $49 ly- 
sate;  (lane  9)  preim- 
mune  serum  to  Adh  + 
cells  (No.  2558)  Adh  + 
lysate;  and  (lane  I0) 
antiserum to Adh  + cells 
(No.  2558),  Adh  + lysate.  Lanes  1 and  2  show  lighter photographic exposures to allow visualization of the  major proteins  in  whole-cell 
extracts. The labels at the right indicate the position of the three protein bands (molecular weight x  10  -3) specific to the anti-Adh  + serum 
and Adh  + extracts. 
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adsorbed the immunoprecipitating activity present in the anti- 
T-25-Adh antiserum. This result argues that these Adh anti- 
gens are only quantitatively elevated on the T-25-Adh cells 
and suggests that these antigens have a  surface localization, 
since intact T-25 cells were used for the adsorption. 
Sera from BALB/c mice immunized with 2  x  107 live T- 
25-Adh cells were also found to detect differences in proteins 
immunoprecipitated from T-25  and  T-25-Adh extracts.  As 
FIGURE  6  Adsorption ofanti-T-25-Adh serum with T-25 cells. Rab- 
bit antiserum to T-25-Adh cells (No. 2558),  0.5 ml, was adsorbed 
three times for  1 h  at 4"C  with  107  T-25  cells which  had  been 
washed in PBS. [3SS]methionine-labeled  extracts of T-25 and T-25- 
Adh cells  were prepared and immunoprecipitated with adsorbed 
or unadsorbed sera as described in  Materials and  Methods. Ad- 
sorbed and nonadsorbed antisera  were Iyophilized and reconsti- 
tuted  before use.  (lane  a) 5  #1  of  unlyophilized antiserum, T-25 
extract; (lane b) 5 ~1 of lyophilized preimmune serum, T-25-Adh 
extract; (lane c) 5 ~,1 of lyophilized unadsorbed antiserum, T-25-Adh 
extract;  (lane  d)  5  ~zl  of  lyophilized adsorbed serum,  T-25-Adh 
extract; and (lane e) 5/~1  of lyophilized  adsorbed serum, T-25 extract. 
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FIGURE  7  Immunoprecipitation of proteins from T-25  and  T-25- 
Adh cells by sera from BALS/c mice. Mice were immunized with 2 
x  10  z live T-25-Adh cells and immunoprecipitations were carried 
out as described in Materials and Methods using 107 trichloroacetic 
acid-precipitable cpm of [35S]methionine-labeled  extracts.  (lane  1) 
T-25-Adh extract with normal (BALB/c) mouse serum; (lane 2) T-25 
cell extract with normal (BALB/c)  mouse serum; (lane 3) T-25-Adh 
cell extract with immune BAL8/c mouse serum; (lane 4) T-25  cell 
extract with immune BALB/c  mouse serum; (lane 5) T-25-Adh cell 
extract with goat anti-murine leukemia virus  serum. 
shown in Fig. 7, lanes 3 (T-25-Adh) and 4 (T-25), the 72,000- 
and  34,000-mol-wt  antigens  observed with  the  rabbit, anti- 
serum were also detected with the mouse antiserum, but the 
61,000-mol-wt antigen was not. Several other differences be- 
tween  T-25 and  T-25-Adh  cells were seen as well,  and  the 
significance of these changes is currently under investigation. 
Fig. 7, lane 5, shows an immunoprecipitation ofa T-25-Adh 
extract with  anti-MuLV serum,  demonstrating  clearly that 
the  viral  gp70  recognized  by this  antiserum  does  not  co- 
migrate with  the  72,000-mol-wt  protein  recognized  by the 
mouse or rabbit anti-T-25-Adh sera. 
DISCUSSION 
Our results demonstrate that in $49 mouse lymphoma cells, 
an inverse correlation (similar to the one in fibroblastoid cells) 
exists between cell  adhesiveness and tumorigenicity in  syn- 
geneic BALB/c mice. Taken together with the immunizing 
ability of the adherent variants, these findings suggest that our 
system is a unique model to study the molecular parameters 
involved in  the  relationship  between  cell  adhesiveness and 
growth regulation in malignant lymphoid cells. 
Although the general applicability of our approach is not 
yet known  (and  other  malignant lymphoid cells are  under 
study),  Fogel  and  Schirrmacher  (7)  have  recently  isolated 
substrate-adhering  variants  from  a  metastatic  lymphoma. 
They found that  the adherent  variants lost their metastatic 
potential. Since the selection for adherent variants is in most 
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iants they isolated have not undergone the complete chain of 
events leading to impaired tumorigenicity. If that is the case, 
it would argue against a direct genetic linkage between cell 
adhesiveness and decreased  tumorigenicity.  Further studies 
(complementation as well as revertant analysis) are required 
to clarify  this question. However, irrespective  of the genetic 
linkage between the above-mentioned traits, our findings offer 
a possible new approach for the xenogenization (15) of malig- 
nant lymphoid cells. 
Our preliminary adoptive spleen cell transfer  experiment 
suggests that protection is mediated by an immunologic proc- 
ess that has a cellular basis.  More extensive experimentation 
will be required to determine what functional cell types me- 
diate protection. On the basis of fiow microfluorometry, there 
appears  to be some antibody activity specific for both T-25 
and T-25-Adh cells (Table I). In contrast, these antibodies do 
not react with spleen cells from BALB/c or other mice strains. 
Furthermore, greater  antibody activity may have been seen 
on the T-25-Adh than on the  T-25  target  cells.  This  is in 
accordance with the immunoprecipitations carried  out with 
the rabbit  antiserum against T-25-Adh cells (Figs.  5 and 6) 
and with immunoprecipitations using mouse antisera (Fig. 7). 
These  findings suggest  that the difference  in the biological 
characteristics  between adherent and suspension-growing $49 
cells  is  related  to  the  enhanced  expression  or  a  different 
distribution of a set of proteins in the adherent cells, thereby 
affecting both their tumorigenic potential and their immuniz- 
ing ability. 
The  decreased  expression  of  the  34,000-,  61,000-,  and 
72,000-mol-wt proteins in T-25 cells is interesting in view of 
recent findings by Reading et al.  (22) that malignancies of 
metastatic  murine lymphosarcoma cell  lines correlate with 
decreased cell surface  display of RNA tumor virus envelope 
glycoprotein  gp70.  In  this  study  we  have  found  that  the 
72,000-mol-wt protein  is  probably not related  to gp70  ex- 
pressed  by  murine  leukemia  virus  in  $49  cells,  but  these 
results do not rule out a  relationship of the 72,000-mol-wt 
antigen to gp70 from another endogenous RNA tumor virus 
in $49 cells. Recent results from our laboratory indicate that 
T-25-Adh cells have an altered form of cytoplasmic tubular 
structures after inoculation into syngeneic mice which closely 
resembles viral particles,  suggesting that increased expression 
of viral  antigens could play a role in the decreased tumori- 
genicity of T-25-Adh cells (J. Hochman and N. Mador, un- 
published observations). 
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